Title: 3 HOUSE BILL 2047 By: Stinson
Official Title: 3 HOUSE BILL 2047 By: Stinson
Number of Sections: 1
Source: versions - Introduced
Media Type: application/pdf
Strikethrough Detection: 7 sections found

================================================================================

Section 1:
1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
4
5
6 AS INTRODUCED
7 An Act relating to schools; creating the Emerson Kate
Cole Act; amending 70 O.S. 2021, Section 1-116.3,
8 which relates to school medication policies;
requiring school to call 911 if Epinephrine is
9 administered to a student; mandating school to notify
parent if student experiences possible allergic
10 reaction; requiring school districts to use model
policies; requiring annual training for certain
11 teachers and school employees; prescribing content
and method for training; providing for
12 noncodification; providing an effective date; and
declaring an emergency.
13
14
15 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
16 SECTION 1. NEW LAW A new section of law not to be
17 codified in the Oklahoma Statutes reads as follows:
18 This act shall be known and may be cited as the "Emerson Kate
19 Cole Act".
20 SECTION 2. AMENDATORY 70 O.S. 2021, Section 1-116.3, is
21 amended to read as follows:
22 Section 1-116.3. A. Notwithstanding the provisions of Section
23 1-116.2 of this title, the board of education of each school
24 district shall adopt a policy on or before September 1, 2008, that
Req. No. 10136 Page 1
1 perm its the self-administration of inhaled asthma medication by a
2 student for treatment of asthma, the self-administration of
3 anaphylaxis medication by a student for treatment of anaphylaxis and
4 the self-administration of replacement pancreatic enzymes by a
5 student for treatment of cystic fibrosis. The policy shall require:
6 1. The parent or guardian of the student to authorize in
7 writing the student's self-administration of medication;
8 2. The parent or guardian of the student to provide to the
9 school a written statement from the physician treating the student
10 that the student has asthma, anaphylaxis or cystic fibrosis and is
11 capable of, and has been instructed in the proper method of, self-
12 administration of medication;
13 3. The parent or guardian of the student to provide to the
14 school an emergency supply of the student's medication to be
15 administered pursuant to the provisions of Section 1-116.2 of this
16 title;
17 4. The school district to inform the parent or guardian of the
18 student, in writing, that the school district and its employees and
19 agents shall incur no liability as a result of any injury arising
20 from the self-administration of medication by the student; and
21 5. The parent or guardian of the student to sign a statement
22 acknowledging that the school district shall incur no liability as a
23 result of any injury arising from the self-administration of
24 medication by the student.
Req. No. 10136 Page 2
1 B. The school board of each school district that elects to
2 stock Epinephrine injectors or inhalers shall amend the policy
3 identified in subsection A of this section.
4 1. The amended policy for Epinephrine injectors shall require:
5 a. the school district to inform the parent or guardian
6 of each student, in writing, that a school nurse or
7 school employee trained by a health care professional
8 or trained in correlation with the State Department of
9 Health's Diabetes Management Annual School Training
10 Program may administer, with parent or guardian
11 permission but without a health care provider order,
12 an Epinephrine injection to a student whom the school
13 nurse or trained school employee in good faith
14 believes is having an anaphylactic reaction,
15 b. a waiver of liability executed by a parent or guardian
16 be on file with the school district prior to the
17 administration of an Epinephrine injection pursuant to
18 paragraph 1 of this subsection, and
19 c. the school district to designate the employee
20 responsible for obtaining the Epinephrine injectors at
21 each school site.
22 2. The amended policy for inhalers shall require:
23 a. the school district to inform the parent or guardian
24 of each student, in writing, that a school nurse or
Req. No. 10136 Page 3
1 school employee trained by a health care professional
2 may administer an inhaler to a student whom the school
3 nurse or trained school employee in good faith
4 believes is having respiratory distress,
5 b. the school district to designate the employee
6 responsible for obtaining the inhalers and spacers or
7 holding chambers at each school site, and
8 c. the school district to notify the parent or guardian
9 of a student after administration of an inhaler.
10 C. The school district and its employees and agents shall incur
11 no liability as a result of any injury arising pursuant to the
12 discharge or nondischarge of the powers provided for pursuant to
13 subparagraph a of paragraphs 1 and 2 of subsection B of this
14 section.
15 D. A licensed physician who has prescriptive authority may
16 write a prescription for Epinephrine injectors and inhalers and
17 spacers or holding chambers to the school district in the name of
18 the district as a body corporate specified in Section 5-105 of this
19 title which shall be maintained at each school site. Such physician
20 shall incur no liability as a result of any injury arising from the
21 use of the Epinephrine injectors or the inhalers and spacers or
22 holding chambers.
23 E. The school district may maintain at each school a minimum of
24 two Epinephrine injectors and two inhalers with spacers or holding
Req. No. 10136 Page 4
1 cham bers in a secure location. Provided, however, that nothing in
2 this section shall be construed as creating or imposing a duty on a
3 school district to maintain Epinephrine injectors or inhalers with
4 spacers or holding chambers at a school site or sites.
5 F. In the event a student is believed to be having an
6 anaphylactic reaction or respiratory distress, a school employee
7 shall contact 911 as soon as possible. If Epinephrine is
8 administered to a student, a school employee shall contact 911 as
9 soon as possible. The school district shall notify the parent or
10 guardian of any student who experiences a possible allergic reaction
11 as soon as possible.
12 G. The State Board of Education, in consultation with the State
13 Board of Health, shall develop model policies which school districts
14 may shall use in compliance with this section. The model policies
15 shall include, at a minimum, required annual training for teachers
16 and school employees who are directly responsible for students on
17 the topics of food allergies, recognizing anaphylaxis, and
18 instruction on how to administer Epinephrine. The training shall be
19 completed before the school year begins or upon hiring the teacher
20 or school employee. Documentation certifying completion of the
21 required training shall be retained in the personnel file of the
22 teacher or school employee. The training may be provided online or
23 in person by the school nurse or a recognized food allergy and
24 anaphylaxis training program.
Req. No. 10136 Page 5
1 H. The State Board of Education, in consultation with the State
2 Board of Health, shall promulgate rules to implement this section.
3 I. As used in this section:
4 1. "Medication" means a metered dose inhaler or a dry powder
5 inhaler to alleviate asthmatic symptoms, prescribed by a physician
6 and having an individual label, an anaphylaxis medication used to
7 treat anaphylaxis including but not limited to Epinephrine injectors
8 prescribed by a physician and having an individual label, or
9 replacement pancreatic enzymes prescribed by a physician and having
10 an individual label; and
11 2. "Self-administration" means a student's use of medication
12 pursuant to prescription or written direction from a physician.;
13 3. "Respiratory distress" means the perceived or actual
14 presence of coughing, wheezing or shortness of breath; and
15 4. "Inhaler" means a device that delivers a bronchodilator to
16 alleviate symptoms of respiratory distress that is manufactured in
17 the form of a metered-dose inhaler or dry-powder inhaler and that
18 may include a spacer or holding chamber that attaches to the inhaler
19 to improve the delivery of the bronchodilator.
20 J. The permission for self-administration of asthma,
21 anaphylaxis or replacement pancreatic enzyme medication is effective
22 for the school year for which it is granted and shall be renewed
23 each subsequent school year upon fulfillment of the requirements of
24 this section.
Req. No. 10136 Page 6
1 K. A student who is permitted to self-administer asthma,
2 anaphylaxis or replacement pancreatic enzyme medication pursuant to
3 this section shall be permitted to possess and use a prescribed
4 inhaler, anaphylaxis medication including but not limited to an
5 Epinephrine injector, or replacement pancreatic enzyme medication at
6 all times.
7 SECTION 3. This act shall become effective July 1, 2025.
8 SECTION 4. It being immediately necessary for the preservation
9 of the public peace, health or safety, an emergency is hereby
10 declared to exist, by reason whereof this act shall take effect and
11 be in full force from and after its passage and approval.
12
13 60-1-10136 SW 12/13/24
14
15
16
17
18
19
20
21
22
23
24
Req. No. 10136 Page 7
[DELETED:  P B]
[DELETED:  P]
[DELETED:  P t a t t]
[DELETED:  P t t]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P S 1]


================================================================================

Raw Text:
1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
3 HOUSE BILL 2047 By: Stinson
4
5
6 AS INTRODUCED
7 An Act relating to schools; creating the Emerson Kate
Cole Act; amending 70 O.S. 2021, Section 1-116.3,
8 which relates to school medication policies;
requiring school to call 911 if Epinephrine is
9 administered to a student; mandating school to notify
parent if student experiences possible allergic
10 reaction; requiring school districts to use model
policies; requiring annual training for certain
11 teachers and school employees; prescribing content
and method for training; providing for
12 noncodification; providing an effective date; and
declaring an emergency.
13
14
15 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
16 SECTION 1. NEW LAW A new section of law not to be
17 codified in the Oklahoma Statutes reads as follows:
18 This act shall be known and may be cited as the "Emerson Kate
19 Cole Act".
20 SECTION 2. AMENDATORY 70 O.S. 2021, Section 1-116.3, is
21 amended to read as follows:
22 Section 1-116.3. A. Notwithstanding the provisions of Section
23 1-116.2 of this title, the board of education of each school
24 district shall adopt a policy on or before September 1, 2008, that
Req. No. 10136 Page 1

1 perm its the self-administration of inhaled asthma medication by a
2 student for treatment of asthma, the self-administration of
3 anaphylaxis medication by a student for treatment of anaphylaxis and
4 the self-administration of replacement pancreatic enzymes by a
5 student for treatment of cystic fibrosis. The policy shall require:
6 1. The parent or guardian of the student to authorize in
7 writing the student's self-administration of medication;
8 2. The parent or guardian of the student to provide to the
9 school a written statement from the physician treating the student
10 that the student has asthma, anaphylaxis or cystic fibrosis and is
11 capable of, and has been instructed in the proper method of, self-
12 administration of medication;
13 3. The parent or guardian of the student to provide to the
14 school an emergency supply of the student's medication to be
15 administered pursuant to the provisions of Section 1-116.2 of this
16 title;
17 4. The school district to inform the parent or guardian of the
18 student, in writing, that the school district and its employees and
19 agents shall incur no liability as a result of any injury arising
20 from the self-administration of medication by the student; and
21 5. The parent or guardian of the student to sign a statement
22 acknowledging that the school district shall incur no liability as a
23 result of any injury arising from the self-administration of
24 medication by the student.
Req. No. 10136 Page 2

1 B. The school board of each school district that elects to
2 stock Epinephrine injectors or inhalers shall amend the policy
3 identified in subsection A of this section.
4 1. The amended policy for Epinephrine injectors shall require:
5 a. the school district to inform the parent or guardian
6 of each student, in writing, that a school nurse or
7 school employee trained by a health care professional
8 or trained in correlation with the State Department of
9 Health's Diabetes Management Annual School Training
10 Program may administer, with parent or guardian
11 permission but without a health care provider order,
12 an Epinephrine injection to a student whom the school
13 nurse or trained school employee in good faith
14 believes is having an anaphylactic reaction,
15 b. a waiver of liability executed by a parent or guardian
16 be on file with the school district prior to the
17 administration of an Epinephrine injection pursuant to
18 paragraph 1 of this subsection, and
19 c. the school district to designate the employee
20 responsible for obtaining the Epinephrine injectors at
21 each school site.
22 2. The amended policy for inhalers shall require:
23 a. the school district to inform the parent or guardian
24 of each student, in writing, that a school nurse or
Req. No. 10136 Page 3

1 school employee trained by a health care professional
2 may administer an inhaler to a student whom the school
3 nurse or trained school employee in good faith
4 believes is having respiratory distress,
5 b. the school district to designate the employee
6 responsible for obtaining the inhalers and spacers or
7 holding chambers at each school site, and
8 c. the school district to notify the parent or guardian
9 of a student after administration of an inhaler.
10 C. The school district and its employees and agents shall incur
11 no liability as a result of any injury arising pursuant to the
12 discharge or nondischarge of the powers provided for pursuant to
13 subparagraph a of paragraphs 1 and 2 of subsection B of this
14 section.
15 D. A licensed physician who has prescriptive authority may
16 write a prescription for Epinephrine injectors and inhalers and
17 spacers or holding chambers to the school district in the name of
18 the district as a body corporate specified in Section 5-105 of this
19 title which shall be maintained at each school site. Such physician
20 shall incur no liability as a result of any injury arising from the
21 use of the Epinephrine injectors or the inhalers and spacers or
22 holding chambers.
23 E. The school district may maintain at each school a minimum of
24 two Epinephrine injectors and two inhalers with spacers or holding
Req. No. 10136 Page 4

1 cham bers in a secure location. Provided, however, that nothing in
2 this section shall be construed as creating or imposing a duty on a
3 school district to maintain Epinephrine injectors or inhalers with
4 spacers or holding chambers at a school site or sites.
5 F. In the event a student is believed to be having an
6 anaphylactic reaction or respiratory distress, a school employee
7 shall contact 911 as soon as possible. If Epinephrine is
8 administered to a student, a school employee shall contact 911 as
9 soon as possible. The school district shall notify the parent or
10 guardian of any student who experiences a possible allergic reaction
11 as soon as possible.
12 G. The State Board of Education, in consultation with the State
13 Board of Health, shall develop model policies which school districts
14 may shall use in compliance with this section. The model policies
15 shall include, at a minimum, required annual training for teachers
16 and school employees who are directly responsible for students on
17 the topics of food allergies, recognizing anaphylaxis, and
18 instruction on how to administer Epinephrine. The training shall be
19 completed before the school year begins or upon hiring the teacher
20 or school employee. Documentation certifying completion of the
21 required training shall be retained in the personnel file of the
22 teacher or school employee. The training may be provided online or
23 in person by the school nurse or a recognized food allergy and
24 anaphylaxis training program.
Req. No. 10136 Page 5

1 H. The State Board of Education, in consultation with the State
2 Board of Health, shall promulgate rules to implement this section.
3 I. As used in this section:
4 1. "Medication" means a metered dose inhaler or a dry powder
5 inhaler to alleviate asthmatic symptoms, prescribed by a physician
6 and having an individual label, an anaphylaxis medication used to
7 treat anaphylaxis including but not limited to Epinephrine injectors
8 prescribed by a physician and having an individual label, or
9 replacement pancreatic enzymes prescribed by a physician and having
10 an individual label; and
11 2. "Self-administration" means a student's use of medication
12 pursuant to prescription or written direction from a physician.;
13 3. "Respiratory distress" means the perceived or actual
14 presence of coughing, wheezing or shortness of breath; and
15 4. "Inhaler" means a device that delivers a bronchodilator to
16 alleviate symptoms of respiratory distress that is manufactured in
17 the form of a metered-dose inhaler or dry-powder inhaler and that
18 may include a spacer or holding chamber that attaches to the inhaler
19 to improve the delivery of the bronchodilator.
20 J. The permission for self-administration of asthma,
21 anaphylaxis or replacement pancreatic enzyme medication is effective
22 for the school year for which it is granted and shall be renewed
23 each subsequent school year upon fulfillment of the requirements of
24 this section.
Req. No. 10136 Page 6

1 K. A student who is permitted to self-administer asthma,
2 anaphylaxis or replacement pancreatic enzyme medication pursuant to
3 this section shall be permitted to possess and use a prescribed
4 inhaler, anaphylaxis medication including but not limited to an
5 Epinephrine injector, or replacement pancreatic enzyme medication at
6 all times.
7 SECTION 3. This act shall become effective July 1, 2025.
8 SECTION 4. It being immediately necessary for the preservation
9 of the public peace, health or safety, an emergency is hereby
10 declared to exist, by reason whereof this act shall take effect and
11 be in full force from and after its passage and approval.
12
13 60-1-10136 SW 12/13/24
14
15
16
17
18
19
20
21
22
23
24
Req. No. 10136 Page 7

[DELETED:  P B]
[DELETED:  P]
[DELETED:  P t a t t]
[DELETED:  P t t]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P S 1]